Guo, Chuanlong

New nanomicelle curcumin formulation for ocular delivery: Improved stability, solubility, and ocular anti-inflammatory treatment

Li, M., Xin, M., Guo, C., Lin, G., & Wu, X. (2017) · Drug Development and Industrial Pharmacy

Advanced Drug Delivery SystemsCurcumin's Biomedical Applications

Cited by 103

Hypoxic bone marrow mesenchymal stromal cells‐derived exosomal miR ‐182‐5p promotes liver regeneration via FOXO1 ‐mediated macrophage polarization

Xu, J., Chen, P., Yu, C., Shi, Q., Wei, S., Li, Y., Qi, H., Cao, Q., Guo, C., Wu, X., et al. (2022) · The FASEB Journal

Extracellular vesicles in diseaseMesenchymal stem cell research

Cited by 58

Copolymer micelle-administered melatonin ameliorates hyperosmolarity-induced ocular surface damage through regulating PINK1-mediated mitophagy

Xu, J., Chen, P., Zhao, G., Wei, S., Li, Q., Guo, C., Cao, Q., Wu, X., & Di, G. (2022) · Current Eye Research

Ocular Surface and Contact LensAdvanced Drug Delivery Systems

Cited by 26

Novel PARP inhibitor DDPF-20 induces DNA damage and inhibits angiogenesis through the PI3K/Akt/VEGF pathway

Wang, T., Zhang, D., Guo, C., & Zhu, W. (2022) · Anti-Cancer Agents in Medicinal Chemistry

PARP inhibition in cancer therapyAngiogenesis and VEGF in Cancer

Cited by 4